Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Jara-Palomares (Sevilla, Spain), S. Marin-Romero (Sevilla, Spain), M. Asensio-Cruz (Sevilla, Spain), T. Elias-Hernandez (Sevilla, Spain), R. Ortega-Rivera (Sevilla, Spain), R. Otero-Candelera (Sevilla, Spain), E. Montero-Romero (Sevilla, Spain), R. Tallon-Aguilar (Sevilla, Spain), M. Ucero-Leon (Sevilla, Spain), M. Arellano-Ceballos (Sevilla, Spain), M. Ruiz-Serrano De La Espada (Sevilla, Spain), C. Fernandez-Garcia (Sevilla, Spain), J. Sanchez-Diaz (Sevilla, Spain), V. Sanchez-Lopez (Sevilla, Spain), E. Arellano-Orden (Sevilla, Spain), M. Ferrer-Galvan (Sevilla, Spain), S. Barco (Mainz, Germany). Anti-Factor Xa levels correlate with recurrent venous thromboembolism and clinically relevant bleeding in patients receiving low-molecular-weight heparin.. 1460

Member's Comments

No comment yet.

Related content which might interest you: Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment Source: Eur Respir J 2016; 48: 1369-1376 Year: 2016 Rivaroxaban versus low-molecular-weight heparin for venous thromboembolism in gastrointestinal and pancreatobiliary cancer Source: International Congress 2018 – Diagnosis, prognostication and treatment of pulmonary embolism Year: 2018 Direct oral anticoagulants and low-molecular weight heparin for primary prevention of venous thromboembolism in cancer patients: a meta-analysis Source: Virtual Congress 2020 – From diagnosis to management of pulmonary embolism Year: 2020 Evaluation of VTE-BLEED for predicting intracranial or fatal bleeding in stable anticoagulated patients with venous thromboembolism Source: Eur Respir J, 51 (4) 1800077; 10.1183/13993003.00077-2018 Year: 2018 Does D-dimer levels on admission predicts venous thromboembolism in patients with COVID-19? Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors Year: 2021 A single centre experience of low dose direct oral anticoagulants (DOAC) after unprovoked venous thromboembolism (VTE) Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism Year: 2019 Low-molecular-weight heparin versus unfractionated heparin in acute pulmonary thromboembolism Source: Eur Respir J 2001; 18: Suppl. 33, 381s Year: 2001 Complications of anticoagulant therapy in patients with pulmonary thromboembolism Source: Eur Respir J 2007; 30: Suppl. 51, 604s Year: 2007 Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients Source: Eur Respir J, 56 (4) 2001811; 10.1183/13993003.01811-2020 Year: 2020 Enoxaparin versus unfractionated heparin in acute pulmonary thromboembolism Source: Eur Respir J 2002; 20: Suppl. 38, 237s Year: 2002 Guided duration of anticoagulation after unprovoked venous thromboembolism using D-dimer testing Source: Eur Respir J 2016; 47:1313-1314 Year: 2016 Predicting anticoagulant-related bleeding in patients with venous thromboembolism: a clinically oriented review Source: Eur Respir J 2015; 45: 201-210 Year: 2015 Plasma high fibrinogen and low plasminogen levels predict poor prognosis in patients with inoperable chronic thromboembolic pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012 D-dimer in patients with venous thromboembolism who carry hereditary thrombophilia Source: Eur Respir J 2006; 28: Suppl. 50, 46s Year: 2006 Efficacy and safety of treatment with anticoagulants in patients with unprovoked venous thromboembolism in Korea Source: International Congress 2016 – Acute pulmonary embolism Year: 2016 Risks of pulmonary thromboembolism associated with ambulatory management of clinically proven deep vein thrombosis Source: Annual Congress 2005 - News about pulmonary embolism Year: 2005 The incidence of venous thromboembolism recurrence in patients after first episode acute pulmonary embolism and related risk factors Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 Factors that predict the risk of recurrent venous thromboembolism (VTE) in patients with VTE and factor V Leiden (FVL) Source: Annual Congress 2010 - Pulmonary embolism Year: 2010 Over reliance on D-dimer requests in the diagnosis of venous thromboembolism (VTE) Source: Eur Respir J 2003; 22: Suppl. 45, 220s Year: 2003 Effectiveness of anticoagulation with unfractionated heparin for acute pulmonary embolism Source: Virtual Congress 2021 – Insights into pulmonary embolism Year: 2021